Amgen (AMGN) Other Gross PP&E Adjustments (2009 - 2026)
Amgen's quarterly Other Gross PP&E Adjustments came in at -$2.7 billion in Q1 2026, up 12.9% year-on-year from -$2.4 billion in Q1 2025, and down 114.29% quarter-over-quarter from $18.9 billion in Q4 2025.
Amgen has reported Other Gross PP&E Adjustments for 18 years, with the latest figure at -$2.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 12.9% year-over-year to -$2.7 billion; the trailing twelve-month figure through Mar 2026 stood at -$8.7 billion (up 15.53% YoY), and the FY2025 full-year result was $18.9 billion, up 12.46% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$2.7 billion, down from $18.9 billion in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $18.9 billion in Q4 2025, with the low at -$3.6 billion in Q1 2024.
- Average Other Gross PP&E Adjustments over 5 years is $2.2 billion, with a median of -$1.3 billion recorded in 2022.
- Year-over-year, Other Gross PP&E Adjustments soared 69.6% in 2023 and sank 71.43% in 2024.
- Tracing AMGN's Other Gross PP&E Adjustments over 5 years: stood at $9.2 billion in 2022, then soared by 69.6% to $15.6 billion in 2023, then gained by 7.77% to $16.8 billion in 2024, then advanced by 12.46% to $18.9 billion in 2025, then sank by 114.29% to -$2.7 billion in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$2.7 billion (Q1 2026), $18.9 billion (Q4 2025), and -$900.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 49.60 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -2.70 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 8.42 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -1.53 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.70 Bn |
| Mar 31, 2026 | -2.70 Bn |
| Dec 31, 2025 | 18.90 Bn |
| Dec 31, 2025 | 18.90 Bn |
| Sep 30, 2025 | -900.00 Mn |
| Sep 30, 2025 | -900.00 Mn |
| Jun 30, 2025 | -2.00 Bn |
| Jun 30, 2025 | -2.00 Bn |
| Mar 31, 2025 | -3.10 Bn |
| Mar 31, 2025 | -3.10 Bn |
| Dec 31, 2024 | 16.80 Bn |
| Dec 31, 2024 | 16.80 Bn |
| Sep 30, 2024 | -1.20 Bn |
| Sep 30, 2024 | -1.20 Bn |
| Jun 30, 2024 | -2.40 Bn |
| Jun 30, 2024 | -2.40 Bn |
| Mar 31, 2024 | -3.60 Bn |
| Mar 31, 2024 | -3.60 Bn |
| Dec 31, 2023 | 15.59 Bn |
| Dec 31, 2023 | 15.59 Bn |
| Sep 30, 2023 | -700.00 Mn |
| Sep 30, 2023 | -700.00 Mn |
| Jun 30, 2023 | -1.40 Bn |
| Jun 30, 2023 | -1.40 Bn |
| Mar 31, 2023 | -2.10 Bn |
| Mar 31, 2023 | -2.10 Bn |
| Dec 31, 2022 | 9.19 Bn |
| Dec 31, 2022 | 9.19 Bn |
| Sep 30, 2022 | -600.00 Mn |
| Sep 30, 2022 | -600.00 Mn |
| Jun 30, 2022 | -1.30 Bn |
| Jun 30, 2022 | -1.30 Bn |
| Mar 31, 2022 | -1.90 Bn |
| Mar 31, 2022 | -1.90 Bn |
| Dec 31, 2021 | 7.82 Bn |
| Dec 31, 2021 | 7.82 Bn |
| Sep 30, 2021 | -600.00 Mn |
| Sep 30, 2021 | -600.00 Mn |
| Jun 30, 2021 | -1.20 Bn |
| Jun 30, 2021 | -1.20 Bn |
| Mar 31, 2021 | -1.90 Bn |
| Mar 31, 2021 | -1.90 Bn |
| Dec 31, 2020 | 7.88 Bn |
| Dec 31, 2020 | 7.88 Bn |
| Sep 30, 2020 | -700.00 Mn |
| Sep 30, 2020 | -700.00 Mn |
| Jun 30, 2020 | -1.40 Bn |
| Jun 30, 2020 | -1.40 Bn |
| Mar 31, 2020 | -2.10 Bn |
| Mar 31, 2020 | -2.10 Bn |
| Dec 31, 2019 | 5.97 Bn |
| Dec 31, 2019 | 5.97 Bn |
| Sep 30, 2019 | -300.00 Mn |
| Sep 30, 2019 | -300.00 Mn |
| Jun 30, 2019 | -600.00 Mn |
| Jun 30, 2019 | -600.00 Mn |
| Mar 31, 2019 | -1.00 Bn |
| Mar 31, 2019 | -1.00 Bn |
| Dec 31, 2018 | 5.77 Bn |
| Dec 31, 2018 | 5.77 Bn |
| Sep 30, 2018 | -300.00 Mn |
| Sep 30, 2018 | -300.00 Mn |
| Jun 30, 2018 | -700.00 Mn |
| Jun 30, 2018 | -700.00 Mn |
| Mar 31, 2018 | -1.00 Bn |
| Mar 31, 2018 | -1.00 Bn |
| Dec 31, 2017 | 4.98 Bn |
| Dec 31, 2017 | 4.98 Bn |
| Sep 30, 2017 | -300.00 Mn |
| Sep 30, 2017 | -300.00 Mn |
| Jun 30, 2017 | -600.00 Mn |
| Jun 30, 2017 | -600.00 Mn |
| Mar 31, 2017 | -1.00 Bn |
| Mar 31, 2017 | -1.00 Bn |
| Dec 31, 2016 | 3.66 Bn |
| Dec 31, 2016 | 3.66 Bn |
| Sep 30, 2016 | -372.00 Mn |
| Sep 30, 2016 | -372.00 Mn |
| Jun 30, 2016 | -700.00 Mn |
| Jun 30, 2016 | -700.00 Mn |
| Mar 31, 2016 | -1.10 Bn |
| Mar 31, 2016 | -1.10 Bn |
| Dec 31, 2015 | 5.74 Bn |
| Dec 31, 2015 | 5.74 Bn |
| Sep 30, 2015 | -348.00 Mn |
| Sep 30, 2015 | -348.00 Mn |
| Jun 30, 2015 | -672.00 Mn |
| Jun 30, 2015 | -672.00 Mn |
| Mar 31, 2015 | -1.00 Bn |
| Mar 31, 2015 | -1.00 Bn |
| Dec 31, 2014 | 5.75 Bn |
| Dec 31, 2014 | 5.75 Bn |
| Sep 30, 2014 | -334.00 Mn |
| Sep 30, 2014 | -334.00 Mn |
| Jun 30, 2014 | -670.00 Mn |
| Jun 30, 2014 | -670.00 Mn |
| Mar 31, 2014 | -951.00 Mn |
| Mar 31, 2014 | -951.00 Mn |
| Dec 31, 2013 | 3.60 Bn |
| Dec 31, 2013 | 3.60 Bn |
| Dec 31, 2012 | 5.36 Bn |
| Dec 31, 2012 | 5.36 Bn |
| Sep 30, 2012 | -103.00 Mn |
| Sep 30, 2012 | -103.00 Mn |
| Jun 30, 2012 | -206.00 Mn |
| Jun 30, 2012 | -206.00 Mn |
| Mar 31, 2012 | -291.00 Mn |
| Mar 31, 2012 | -291.00 Mn |
| Dec 31, 2011 | 3.28 Bn |
| Dec 31, 2011 | 3.28 Bn |
| Dec 31, 2010 | 3.12 Bn |
| Dec 31, 2010 | 3.12 Bn |
| Dec 31, 2009 | 4.71 Bn |
| Dec 31, 2009 | 4.71 Bn |